Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease

Clinical trial NCT01394926 · TERMINATED

Trial details

NCT number: NCT01394926
Sponsor: GE Healthcare
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Carotid Artery Disease

Start date: 2011-06-01
Primary completion: 2012-06-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.